Panion & Bf Biotech (TPE:1760) Accounts Payable & Accrued Expense : NT$492 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Panion & Bf Biotech Accounts Payable & Accrued Expense?

Panion & Bf Biotech's quarterly accounts payable & accrued expense increased from Sep. 2023 (NT$383 Mil) to Dec. 2023 (NT$423 Mil) and increased from Dec. 2023 (NT$423 Mil) to Mar. 2024 (NT$492 Mil).

Panion & Bf Biotech's annual accounts payable & accrued expense increased from Dec. 2021 (NT$355 Mil) to Dec. 2022 (NT$445 Mil) but then declined from Dec. 2022 (NT$445 Mil) to Dec. 2023 (NT$423 Mil).

Panion & Bf Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Panion & Bf Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panion & Bf Biotech Accounts Payable & Accrued Expense Chart

Panion & Bf Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

309.89

371.44

355.08

445.22

423.35

Panion & Bf Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															553.41	579.88	382.75	423.35	491.98

Panion & Bf Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Panion & Bf Biotech (TPE:1760) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panion & Bf Biotech Inc (TPE:1760) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 16th Floor, F Building, Nangang District, Taipei, TWN, 11503

Website

https://www.pbf.com.tw

Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. It is engaged in research and development of pharmaceuticals and new drugs. It focuses on pharmaceuticals, cosmeceuticals, nutraceuticals, and medical devices sectors. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generate majority of the revenue from Taiwan segment.

Panion & Bf Biotech (TPE:1760) Headlines

No Headlines